PROBLEM TO BE SOLVED: To provide a method of identifying a subject eligible to administration of at least one medicament selected from a group consisting of a beta blocker, aldosterone antagonist, diuretic, and renin-angiotensin system inhibitor.SOLUTION: A method disclosed herein is based on determination of an amount of at least one biomarker selected from a group consisting of; GDF-15 (Growth Differentiation Factor 15), endostatin, mimecan, IGFBP7 (IGF binding protein 7), cardiac Troponin, BNP-type peptide, uric acid, Gal3 (Galectin-3), osteopontin, sST2 (soluble ST2), PlGF, sFlt-1, P1NP, Cystatin C, Prealbumin, and Transferrin in a sample collected from a subject suffering from heart failure. The method also comprises a step of comparing the determined amount of the biomarker with a reference amount. Also disclosed are a method, kit, and device for identifying a subject eligible to administration of at least one medicament from a result of the above step.SELECTED DRAWING: None
BIOMARKERS FOR SELECTING HEART FAILURE THERAPY